[Studies on the effect of oral contraceptives and epsilon-aminocaproic acid on pregnant rats and their fetuses with particular attention to the coagulation tests].
Explore the source record for details and available documents.
Afibrinogenemia↗
SEARCH · Search PubMed
Results for “AMINOCAPROIC ACID”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
Explore the source record for details and available documents.
Aminocaproates↗
Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.
Explore the source record for details and available documents.
Aminocaproates↗
Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
Explore the source record for details and available documents.
Administration, Oral↗
Diffusion of epsilon aminocaproic acid to the joints.
Explore the source record for details and available documents.
Aminocaproates↗
[Fibrinolytic activity of blood and tonsillar tissue in patients with chronic tonsillar tissue in patients with chronic tonsillitis after tonsillectomy with local use of epsilon-aminocaproic acid].
Explore the source record for details and available documents.
Adolescent↗
[Sudden relief of symptoms in a patient with mesangiocapillary glomerulonephritis during treatment of hematuria with epsilon aminocaproic acid].
A case of not expected turn in the course of mesangiocapillary glomerulonephritis in a 30-year old patient is presented. The patient has been treated with EACA. It confirms possible efficiency of EACA inhibitory effect on various immunological reactions. This new, unknown property of EACA justify some new concepts in pathogenetic mechanisms of glomerulopathy.
Adult↗
[Experimental pulmonary embolisms treated with fibrinolysin and epsilon-aminocaproic acid].
Explore the source record for details and available documents.
Aminocaproates↗
[Value of epsilon-aminocaproic acid in radiological examinations].
Explore the source record for details and available documents.
Aminocaproates↗
Modification of delayed skin reaction by epsilon-aminocaproic acid.
Explore the source record for details and available documents.
Administration, Oral↗
Aminocaproic acid for haemophilia.
Explore the source record for details and available documents.
Aminocaproates↗
Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid.
Explore the source record for details and available documents.
Adolescent↗
[Epsilon-aminocaproic acid in surgery].
Explore the source record for details and available documents.
Aminocaproates↗
[2 cases of hemophilia A treated with epsilon-aminocaproic acid (EACA)].
Explore the source record for details and available documents.
Aminocaproates↗
[On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)].
Explore the source record for details and available documents.
Adolescent↗
Aminocaproic acid in haemophilia and in menorrhagia.
Explore the source record for details and available documents.
Aminocaproates↗
Topical aminocaproic acid (Amicar).
Explore the source record for details and available documents.
Administration, Topical↗
[Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant].
A premature infant of 31 weeks gestational age weighing 1650 g developed pronounced generalized bleeding following exchange transfusion for rhesus-incompatibility. As a consequence there was continuous leakage into a subcutaneous haematoma that had been caused by accidental puncture of the infant's flank during diagnostic amniocentesis. The ensuing massive and prolonged loss of blood required replacement by infusions of heparinized fresh blood over several days. The most conspicuous detail in the longitudinal study of haemostasis was hyperfibrinolysis with values for Fibrin-Fibrinogen Split Products exceeding 1280 micrograms/ml. This situation could be treated effectively with epsilon-amino-capronic acid. We suggest that anti-fibrinolytic agents can be recommended under cover of heparin for treating those rare cases in which hyperfibrinolysis predominates and clinical criteria of disseminated intravascular thrombosis are missing. We would, however, strongly discourage the uncritical use of antifibrinolytic agents whenever Fibrin-Fibrinogen-Split Products are detected.
Aminocaproates↗